Gibson Christopher
SEC CIK 1856369 · EDGAR
BoughtSold
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Transactions 305
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-08+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | +6,574 | 29.0K | +29% | $0 |
| MI | 2021-12-09 | 2021-12-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | CEO, Dir | S - Sale | $20.51 | -3,125 | 146.9K | -2% | -$64.1K |
| M | 2021-12-09 | 2021-12-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | CEO, Dir | S - Sale | $20.48 | -16.7K | 8.20M | -0.2% | -$341.3K |
| 2021-12-09 | 2021-11-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | -1.10M | 8.22M | -12% | $0 | |
| MI | 2021-12-09 | 2021-11-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | +1.10M | 550.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations